Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01420172|
Recruitment Status : Completed
First Posted : August 19, 2011
Last Update Posted : February 27, 2017
This will be a retrospective study and analysis of subjects who have undergone a hematopoietic stem transplant (either at OSUMC or external location) and were seen at OSUMC at any time between 01Jan2000 and 30Jun2011.
This study will determine factors influencing pulmonary disease and associated treatment strategies.
|Condition or disease||Intervention/treatment|
|Post Hematopoietic Stem Cell Transplantation||Other: Data Collection|
|Study Type :||Observational|
|Actual Enrollment :||200 participants|
|Official Title:||Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.|
|Study Start Date :||August 2011|
|Actual Primary Completion Date :||July 8, 2016|
|Actual Study Completion Date :||July 8, 2016|
Post hematopoietic stem cell transplantation
Patients who were seen post hematopoietic stem cell transplantation between 01Jan2000 and 30Jun2011
Other: Data Collection
Collection of data on patients who were seen at OSUMC at any time between 01Jan2000 and 30Jun2011 post hematopoietic stem cell transplantation
- A retrospective diagnostic review on pulmonary disease related to hematopoietic stem cell transplantation. [ Time Frame: Up to 15 years ]To determine factors influencing pulmonary disease related to HSCT.
- A retrospective treatment review on treatment strategies for pulmonary disease related to hematopoietic stem cell transplantation. [ Time Frame: Up to 15 years ]To review treatment strategies for pulmonary disease post transplant for effectiveness.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01420172
|United States, Ohio|
|The Ohio State University Medical Center|
|Columbus, Ohio, United States, 43221|